Regulatory factor X1 is a new tumor suppressive transcription factor that acts via direct downregulation of CD44 in glioblastoma

Neuro-Oncology

Volumn 16, Issue 8, 2014, Pages 1078-1085

  Feng, Chenzhuo ^a   Zhang, Ying ^a   Yin, Jinbo ^a,b   Li, Jun ^a,c   Abounader, Roger ^a   Zuo, Zhiyi ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

CD44; Glioblastoma; Regulatory factor X1

Indexed keywords

DNA FRAGMENT; HERMES ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR X1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; CD44 PROTEIN, HUMAN; CD44 PROTEIN, MOUSE; DNA BINDING PROTEIN; REGULATORY FACTOR X TRANSCRIPTION FACTORS;

APOPTOSIS; ARTICLE; BINDING SITE; CANCER GROWTH; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; EXON; GENE SEQUENCE; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN BINDING; PROTEIN EXPRESSION; REGULATORY MECHANISM; TUMOR INVASION; XENOGRAFT; ANIMAL; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD44; CELL LINE, TUMOR; CELL PROLIFERATION; DNA-BINDING PROTEINS; DOWN-REGULATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLIOBLASTOMA; HUMANS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84904293608     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nou010     Document Type: Article

References (24)

1. Emery P, Durand B, Mach B, et al. RFX proteins, a novel family of DNA binding proteins conserved in the eukaryotic kingdom. Nucleic Acids Res. 1996;24:803-807 (Pubitemid 26076182)
2. Aftab S, Semenec L, Chu JS, et al. Identification and characterization of novel human tissue-specific RFX transcription factors. BMC Evol Biol. 2008;8:226
3. Villard J, Peretti M, Masternak K, et al. A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y. Mol Cell Biol. 2000;20(10):3364-3376 (Pubitemid 30243882)
4. Clausen BE, Waldburger JM, Schwenk F, et al. Residual MHC class II expression on mature dendritic cells and activated B cells in RFX5-deficient mice. Immunity. 1998;8(2):143-155 (Pubitemid 28123742)
5. Ait-Lounis A, Baas D, Barras E, et al. Novel function of the ciliogenic transcription factor RFX3 in Development of the endocrine pancreas. Diabetes. 2007;56(4):950-959 (Pubitemid 46525062)
6. Bonnafe E, Touka M, Ait-Lounis A, et al. The transcription factor RFX3 directs nodal cilium development and left-right asymmetry specification. Mol Cell Biol. 2004;24(10):4417-4427 (Pubitemid 41071011)
7. Chen L, Smith L, Johnson MR, et al. Activation of protein kinase C induces nuclear translocation of RFX1 and down-regulates c-myc via an intron 1 X box in undifferentiated leukemia HL-60 cells. J Biol Chem. 2000;275(41):32227- 32233
8. Ohashi Y, Ueda M, Kawase T, et al. Identification of an epigenetically silenced gene, RFX1, in human glioma cells using restriction landmark genomic scanning. Oncogene. 2004;23(47):7772-7779 (Pubitemid 39457027)
9. Watts JA, Zhang C, Klein-Szanto AJ, et al. Study of FoxA pioneer factor at silent genes reveals Rfx-repressed enhancer at Cdx2 and a potential indicator of esophageal adenocarcinoma development. PLoS Genet. 2011;7(9):e1002277
10. Feng C, Zuo Z. Regulatory factor X1-induced down-regulation of transforming growth factor beta 2 transcription in human neuroblastoma cells. J Biol Chem. 2012;287(27):22730-22739
11. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human Disease. N Engl J Med. 2000;342(18): 1350-1358 (Pubitemid 30408720)
12. Bourguignon LY, Singleton PA, Zhu H, et al. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. J Biol Chem. 2002;277(42):39703-39712 (Pubitemid 35190953)
13. Toole BP. Hyaluronan-CD44 interactions in cancer: Paradoxes and possibilities. Clin Cancer Res. 2009;15(24):7462-7468
14. Turley EA, Noble PW, Bourguignon LY. Signaling properties of hyaluronan receptors. J Biol Chem. 2002;277(7):4589-4592 (Pubitemid 34968484)
15. Wang SJ, Bourguignon LY. Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. Am J Pathol. 2011;178(3):956-963
16. Xu Y, Stamenkovic I, Yu Q. CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma. Cancer Res. 2010;70(6):2455-2464
17. Ma K, Zheng S, Zuo Z. The transcription factor regulatory factor X1 increases the expression of neuronal glutamate transporter type 3. J Biol Chem. 2006;281(30):21250-21255 (Pubitemid 44115464)
18. Li Y, Guessous F, Zhang Y, et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 2009;69(19): 7569-7576
19. Cao L, Li L, Lin D, et al. Isoflurane induces learning impairment that is mediated by interleukin 1beta in rodents. PLoS One. 2012;7(12): E51431
20. Liu M, Lee BH, Mathews MB. Involvement of RFX1 protein in the regulation of the human proliferating cell nuclear antigen promoter. J Biol Chem. 1999;274(22):15433-15439
21. Hsu YC, Liao WC, Kao CY, et al. Regulation of FGF1 gene promoter through transcription factor RFX1. J Biol Chem. 2010;285(18): 13885-13895
22. Shivji KK, Kenny MK, Wood RD. Proliferating cell nuclear antigen is required for DNA excision repair. Cell. 1992;69(2):367-374
23. Giese A, Bjerkvig R, Berens ME, et al. Cost of migration: Invasion of malignant gliomas and implications for treatment. J Clin Oncol. 2003;21(8):1624-1636 (Pubitemid 46594118)
24. Maher EA, Furnari FB, Bachoo RM, et al. Malignant glioma: Genetics and biology of a grave matter. Genes Dev. 2001;15(11):1311-1333 (Pubitemid 32524640)